RIHAWI, KARIM
 Distribuzione geografica
Continente #
NA - Nord America 735
EU - Europa 612
AS - Asia 336
AF - Africa 53
Totale 1.736
Nazione #
US - Stati Uniti d'America 732
IT - Italia 265
CN - Cina 125
SG - Singapore 90
GB - Regno Unito 80
VN - Vietnam 69
DE - Germania 66
SE - Svezia 64
IE - Irlanda 39
IN - India 28
TG - Togo 27
BG - Bulgaria 18
CH - Svizzera 15
FR - Francia 15
RU - Federazione Russa 12
CI - Costa d'Avorio 11
FI - Finlandia 10
JO - Giordania 10
EE - Estonia 7
UA - Ucraina 7
ZA - Sudafrica 7
HK - Hong Kong 6
NG - Nigeria 6
BE - Belgio 5
ID - Indonesia 5
NL - Olanda 4
AT - Austria 2
CA - Canada 2
CD - Congo 2
TW - Taiwan 2
CZ - Repubblica Ceca 1
GR - Grecia 1
LT - Lituania 1
PA - Panama 1
UZ - Uzbekistan 1
Totale 1.736
Città #
Singapore 86
Chandler 85
Bologna 82
Santa Clara 70
Fairfield 68
Southend 67
Ashburn 57
Houston 45
Woodbridge 44
Dublin 39
Seattle 37
Dong Ket 34
Wilmington 29
Princeton 28
Lomé 27
Boardman 24
Cambridge 23
Florence 21
Sofia 18
Vicenza 18
Beijing 17
Bern 15
Turin 13
Abidjan 11
Amman 10
Helsinki 9
Milan 9
Redmond 9
Shanghai 9
Berlin 8
Bremen 8
Jinan 8
New York 8
Westminster 8
Ann Arbor 7
Forlì 7
Nanjing 7
Abeokuta 6
Los Angeles 6
Tianjin 6
Brussels 5
Hebei 5
Jakarta 5
San Diego 5
Boydton 4
Falls Church 4
Rome 4
Shenyang 4
Bühl 3
Carpi 3
Changsha 3
Fuzhou 3
Hangzhou 3
Hong Kong 3
Medford 3
Naples 3
Padova 3
Paris 3
Redwood City 3
Amsterdam 2
Arzano 2
Cesena 2
Dearborn 2
Des Moines 2
Formigine 2
Groningen 2
Guangzhou 2
Imola 2
Ithaca 2
Kilburn 2
Kinshasa 2
Messina 2
Modena 2
Montelupone 2
Mülheim 2
Palermo 2
Pescara 2
Prescot 2
Pune 2
Rimini 2
Shijiazhuang 2
Taipei 2
Vienna 2
Wuhan 2
Xiamen 2
Bassano Del Grappa 1
Bedford 1
Casalecchio di Reno 1
Castel San Pietro Terme 1
Castenaso 1
Castiglione dei Pepoli 1
Changzhou 1
Chengdu 1
Clearwater 1
Cogollo del Cengio 1
Costa Mesa 1
Cotignola 1
Falkenstein 1
Ferrara 1
Foshan 1
Totale 1.219
Nome #
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding 147
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products. 142
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 135
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence 127
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins 125
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 122
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report 121
Chemotherapy treatment in malignant pleural mesothelioma: A difficult history 116
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience 99
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer 91
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study 83
Expected and non-expected immune-related adverse events detectable by CT 73
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 68
Emerging therapies in malignant pleural mesothelioma 66
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series 65
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications 59
Novel HER2-directed treatments in advanced gastric carcinoma: Another paradigm shift? 54
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 51
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 31
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 24
Immune checkpoint inhibition in small cell lung cancer: A key to reach an unmet need? 14
Totale 1.813
Categoria #
all - tutte 5.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.708


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020173 0 0 0 0 0 21 33 34 40 13 17 15
2020/2021241 23 25 25 0 26 6 12 8 13 9 15 79
2021/2022221 7 2 7 4 17 16 5 27 16 19 60 41
2022/2023537 21 54 12 56 49 68 30 35 88 13 66 45
2023/2024182 16 22 15 15 19 40 5 6 10 21 6 7
2024/2025333 12 78 51 47 102 43 0 0 0 0 0 0
Totale 1.813